Form D/A — Nexo Therapeutics, Inc.
0001955319-26-000001 · filed Mar 27, 2026
Figures are issuer-reported and describe stored filings. Data coverage and methodology.
Check this disclosure on SEC EDGAR · More Biotechnology filings
Offering
- Industry
- Biotechnology
- Exemptions
- Rule 506(b)
- Reported offering amount
- $60,000,000
- Reported amount sold
- $60,000,000
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Nexo Therapeutics, Inc.
- CIK
- 1955319
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- 2022
- Address
- 11757 W. KEN CARYL AVENUE
LITTLETON, Colorado 80127-3719 - Phone
- 303-868-6790
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Andrew Phillips · Executive OfficerLittleton, Colorado Find on LinkedIn ↗
-
Ali Behbahani · DirectorLittleton, Colorado Find on LinkedIn ↗
-
Carlo Rizzuto · DirectorLittleton, Colorado Find on LinkedIn ↗
Other filings from this issuer
View the original filing on SEC EDGAR ↗